58 related articles for article (PubMed ID: 7844217)
1. Effect of GnRH antagonists on clinical pregnancy rates in ovulation induction protocols with gonadotropins and intrauterine insemination.
Dansuk R; Gonenc AI; Sudolmus S; Yucel O; Sevket O; Köroğlu N
Singapore Med J; 2015 Jun; 56(6):353-6. PubMed ID: 25532515
[TBL] [Abstract][Full Text] [Related]
2. A prospective proof-of-concept trial on the effect of personalized dosages of follitropin delta in intrauterine insemination.
Minano Masip J; Kadoch E; Hemmings R; Phillips S; Bissonnette F; Kadoch IJ
Reprod Biomed Online; 2024 Apr; 48(4):103603. PubMed ID: 38359732
[TBL] [Abstract][Full Text] [Related]
3. Ovarian stimulation strategies for intrauterine insemination in couples with unexplained infertility: a systematic review and individual participant data meta-analysis.
Wessel JA; Danhof NA; van Eekelen R; Diamond MP; Legro RS; Peeraer K; D'Hooghe TM; Erdem M; Dankert T; Cohlen BJ; Thyagaraju C; Mol BWJ; Showell M; van Wely M; Mochtar MH; Wang R
Hum Reprod Update; 2022 Aug; 28(5):733-746. PubMed ID: 35587030
[TBL] [Abstract][Full Text] [Related]
4. Agents for ovarian stimulation for intrauterine insemination (IUI) in ovulatory women with infertility.
Cantineau AE; Rutten AG; Cohlen BJ
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD005356. PubMed ID: 34739136
[TBL] [Abstract][Full Text] [Related]
5. Comparison of different starting gonadotropin doses (50, 75 and 100 IU daily) for ovulation induction combined with intrauterine insemination.
Streda R; Mardesic T; Sobotka V; Koryntova D; Hybnerova L; Jindra M
Arch Gynecol Obstet; 2012 Oct; 286(4):1055-9. PubMed ID: 22736041
[TBL] [Abstract][Full Text] [Related]
6. Gn-RH antagonists in intrauterine insemination: the weekend-free protocol.
Matorras R; Ramón O; Expósito A; Corcóstegui B; Ocerin I; Gonzalez-Lopera S; Rodríguez-Escudero FJ
J Assist Reprod Genet; 2006 Feb; 23(2):51-4. PubMed ID: 16552633
[TBL] [Abstract][Full Text] [Related]
7. Oral versus injectable ovulation induction agents for unexplained subfertility.
Athaullah N; Proctor M; Johnson NP
Cochrane Database Syst Rev; 2002; 2002(3):CD003052. PubMed ID: 12137671
[TBL] [Abstract][Full Text] [Related]
8. Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women and WHO group II anovulatory infertile patients.
Balasch J; Fábregues F; Peñarrubia J; Creus M; Vidal R; Casamitjana R; Manau D; Vanrell JA
J Assist Reprod Genet; 1998 Oct; 15(9):552-9. PubMed ID: 9822984
[TBL] [Abstract][Full Text] [Related]
9. Endogenous LH surge versus hCG as ovulation trigger after low-dose highly purified FSH in IUI: a comparison of 761 cycles.
Romeu A; Monzó A; Peiró T; Diez E; Peinado JA; Quintero LA
J Assist Reprod Genet; 1997 Oct; 14(9):518-24. PubMed ID: 9401870
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the role of cervical and intrauterine insemination techniques on the incidence of multiple pregnancy after artificial insemination with donor sperm.
Tur R; Buxaderas C; Martínez F; Busquets A; Coroleu B; Barri PN
J Assist Reprod Genet; 1997 May; 14(5):250-3. PubMed ID: 9147237
[TBL] [Abstract][Full Text] [Related]
11. Follicle stimulating hormone or clomiphene citrate in intrauterine insemination with ovarian stimulation for unexplained subfertility: a role for treatment selection markers?
Danhof NA; van Eekelen R; Repping S; Mol BWJ; van der Veen F; van Wely M; Mochtar MH;
Reprod Biomed Online; 2019 Jun; 38(6):938-942. PubMed ID: 30981620
[TBL] [Abstract][Full Text] [Related]
12. In vitro fertilisation for unexplained subfertility.
Pandian Z; Bhattacharya S; Nikolaou D; Vale L; Templeton A
Cochrane Database Syst Rev; 2002; (2):CD003357. PubMed ID: 12076476
[TBL] [Abstract][Full Text] [Related]
13. Stimulated intra-uterine insemination is not a natural choice for the treatment of unexplained subfertility. 'Effective treatment' or 'not a natural choice'?
Hughes EG
Hum Reprod; 2003 May; 18(5):912-4. PubMed ID: 12721161
[TBL] [Abstract][Full Text] [Related]
14. Late low-dose pure follicle stimulating hormone for ovarian stimulation in intra-uterine insemination cycles.
Balasch J; Ballescá JL; Pimentel C; Creus M; Fábregues F; Vanrell JA
Hum Reprod; 1994 Oct; 9(10):1863-6. PubMed ID: 7844217
[TBL] [Abstract][Full Text] [Related]
15. A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility.
Dankert T; Kremer JA; Cohlen BJ; Hamilton CJ; Pasker-de Jong PC; Straatman H; van Dop PA
Hum Reprod; 2007 Mar; 22(3):792-7. PubMed ID: 17110396
[TBL] [Abstract][Full Text] [Related]
16. An effective alternative to only gonadotrophin for controlled ovarian stimulation in unexplained infertility patients undergoing intra-uterine insemination: a clinical trial.
Chaudhury K; Chaudhury S; Khastgir G; Purakaystha S
J Indian Med Assoc; 2013 Sep; 111(9):589-92, 594. PubMed ID: 24968520
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
